Palvella Therapeutics (PVLA) Receivables - Other (2019 - 2024)
Historic Receivables - Other for Palvella Therapeutics (PVLA) over the last 4 years, with Q3 2024 value amounting to $506000.0.
- Palvella Therapeutics' Receivables - Other changed N/A to $506000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $506000.0, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2023, which is 3416.47% down from last year.
- Latest data reveals that Palvella Therapeutics reported Receivables - Other of $506000.0 as of Q3 2024.
- Over the past 5 years, Palvella Therapeutics' Receivables - Other peaked at $4.8 million during Q4 2022, and registered a low of $506000.0 during Q3 2024.
- For the 3-year period, Palvella Therapeutics' Receivables - Other averaged around $2.9 million, with its median value being $3.1 million (2024).
- Data for Palvella Therapeutics' Receivables - Other shows a peak YoY increase of 3416.47% (in 2023) and a maximum YoY decrease of 3416.47% (in 2023) over the last 5 years.
- Over the past 3 years, Palvella Therapeutics' Receivables - Other (Quarter) stood at $4.8 million in 2022, then plummeted by 34.16% to $3.1 million in 2023, then tumbled by 83.89% to $506000.0 in 2024.
- Its last three reported values are $506000.0 in Q3 2024, $3.0 million for Q2 2024, and $3.1 million during Q1 2024.